Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFEAT-AKI
NCT04633889Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferoxamine in acute kidney injury (AKI), sponsored by Brigham and Women's Hospital. Started Apr 2021; status: completed.
02
Drugs
deferoxamine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04633889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04633889.